All In MedTech

Device Trial Radar · NCT07933549

REstoration of Communication and LAnguage With Intracortical Microelectrodes

Early Feasibility Study of the Restoration of Communication and Language With Intracortical Microelectrodes (RECLAIM) System

Last checked: Nov 20, 2026Latest source record: Nov 12, 2026 (this record)Source: ClinicalTrials.govMethods & limitations

Not yet recruiting

Status

Not yet recruiting

Enrollment

4

Planned (sponsor's estimate)

Start

Nov 1, 2026

Primary completion

Jan 1, 2035

Study completion Apr 1, 2039

Sponsor

Lead sponsor
The University of Texas Health Science Center, HoustonAcademic, hospital or other
Sponsor type
Academic, hospital or other
First posted
Nov 12, 2026

More device trials from this sponsor

Design

Study type
Interventional
Phase
Not applicable (typical for device studies)
Allocation
Not applicable (single group)
Model
Single group
Masking
None
Primary purpose
Other
FDA-regulated device
Yes
Who can join
All sexes, from 22 years, up to 65 years
Healthy volunteers
No

Summary

As written by the sponsor on the registry.

The purpose of this study is to investigate the safety and feasibility of using distributed intracortical recordings from the language network to decode intended language output in individuals with severe communication impairment due to severe communication impairment resulting from amyotrophic lateral sclerosis (ALS), locked-in syndrome, and brain injury including from stroke.

Conditions

  • Amyotrophic Lateral Sclerosis (ALS)
  • locked-in Syndrome
  • Brain Injury
  • Stroke

Interventions

  • RECLAIM SystemDevice

    6 microelectrode grids will be implanted within the dominant hemisphere, placed across key speech and language cortical regions. The device will be kept implanted for up to 5 years and study sessions will be conducted 3-5 times per week

Primary outcomes

What the sponsor says the trial is designed to measure.

  1. Safety as assessed by the number and type of adverse events that occurTime frame: From time of implant to one year post-implant

Locations

1 site in 1 country. Site status is shown where the registry gives one.

  • The University of Texas Health Science Center at Houston

    Houston, Texas

Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.